Stocks · Korea 137310 KOSPI

SD Biosensor

6,850원 +6.53% Market cap 8,271억 2026-10-07 close
Data as of 2026-10-07 · Linked from 8 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR0.35x
EPS0 KRW
BPS19,476 KRW
ROE-19.89%
DPS200 KRW

Returns and 52-week range

1W+12.30%
1M+10.84%
3M+4.74%
6M-12.29%
1Y-36.81%
YTD-24.56%
52W high10,870원
52W low5,800원
From 52W high-36.98%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20222.9조1.1조9,088억39.1%
20236,557억-2,481억-4,679억-37.8%
20246,946억-541억-981억-7.8%
20257,106억-809억-5,134억-11.4%
Quarterly
2024 4Q1,801억-181억-1,342억-10.0%
2025 1Q1,853억-146억-188억-7.9%
2025 2Q1,665억-206억2,751억-12.4%
2025 3Q1,642억-140억-99억-8.5%
2025 4Q1,946억-318억-7,598억-16.4%
2026 1Q1,935억-116억223억-6.0%

Company

CEO이효근
Founded2010-12-27
Fiscal year end12
Address: 경기도 수원시 영통구 덕영대로1556번길 16 씨동 4층, 5층

Peers in the same sector

CompanyMarket capP/EP/B1M
리브스메드9,660억—5.22+15.02%
인바디7,158억21.912.23-9.90%
큐리옥스바이오시스템즈1.0조—19.20+22.31%
케이씨5,207억11.970.61+28.40%
디아이1.2조211.996.61+36.45%
아이센스4,939억—1.46+1.40%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.